Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · IEX Real-Time Price · USD
23.79
+0.37 (1.58%)
Jul 19, 2024, 4:00 PM EDT - Market closed
ARCT Market Cap
ARCT has a market cap or net worth of $640.71 million as of July 22, 2024. Its market cap has decreased by -17.06% in one year.
Market Cap
640.71M
Enterprise Value
324.96M
1-Year Change
-17.06%
Ranking
Category
Stock Price
$23.79
Market Cap Chart
Since October 22, 2013, ARCT's market cap has increased from $222.10M to $640.71M, an increase of 188.48%. That is a compound annual growth rate of 10.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 640.70M | -23.96% |
| Dec 29, 2023 | 842.60M | 87.54% |
| Dec 30, 2022 | 449.30M | -53.95% |
| Dec 31, 2021 | 975.60M | -8.18% |
| Dec 31, 2020 | 1.06B | 546.29% |
| Dec 31, 2019 | 164.40M | 238.97% |
| Dec 31, 2018 | 48.50M | 54.95% |
| Dec 29, 2017 | 31.30M | -45.94% |
| Dec 30, 2016 | 57.90M | -32.75% |
| Dec 31, 2015 | 86.10M | 69.16% |
| Dec 31, 2014 | 50.90M | -79.27% |
| Dec 31, 2013 | 245.50M | 10.54% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mineralys Therapeutics | 655.36M |
| Fulgent Genetics | 652.95M |
| UroGen Pharma | 650.07M |
| Exscientia | 649.15M |
| Acelyrin | 644.67M |
| Phathom Pharmaceuticals | 640.67M |
| Prime Medicine | 636.76M |
| IGM Biosciences | 633.91M |